IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
-$87.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
198
New
Increased
Reduced
Closed

Top Buys

1
+$17.1M
2
+$8.3M
3
+$6.55M
4
CLDX icon
Celldex Therapeutics
CLDX
+$5.75M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$5.39M

Top Sells

1
+$11.5M
2
+$7.89M
3
+$6.85M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.66M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$6.2M

Sector Composition

1 Healthcare 97.45%
2 Consumer Staples 0.57%
3 Technology 0.57%
4 Financials 0.21%
5 Real Estate 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$840K 0.13%
675
77
$840K 0.13%
11,129
78
$804K 0.12%
11,171
-31,259
79
$801K 0.12%
150,484
80
$779K 0.12%
209,082
-101,959
81
$778K 0.12%
46,519
-170,000
82
$751K 0.11%
+41
83
$742K 0.11%
390,394
84
$739K 0.11%
496,756
85
$728K 0.11%
73,789
86
$722K 0.11%
434
+143
87
$697K 0.1%
+17,500
88
$678K 0.1%
32,680
89
$630K 0.09%
553
90
$592K 0.09%
14
91
$584K 0.09%
31,618
92
$562K 0.08%
34,565
93
$554K 0.08%
49,680
-70,215
94
$553K 0.08%
762
-236
95
$528K 0.08%
+9,038
96
$510K 0.08%
47,193
97
$501K 0.07%
17,905
98
$484K 0.07%
36,576
-60,000
99
$473K 0.07%
87,580
100
$467K 0.07%
20,743
2 3
4
5 6